reference/17425932

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17425932

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	105.e1
issn	0002-8703
issueIdentifier	1
pageRange	98-105.e1
publicationName	American Heart Journal
startingPage	98
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7842d4a3c63f3eec2ded513ced2c398f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_61fd2d38d6968565752e91808d5301db
bibliographicCitation	Berger JS, Bhatt DL, Steg PG, Steinhubl SR, Montalescot G, Shao M, Hacke W, Fox KA, Berger PB, Topol EJ, Lincoff AM. Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2011 Jul;162(1):98–105.e1. doi: 10.1016/j.ahj.2011.04.015. PMID: 21742095.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41ab58d6f3c65a58dda247526118d576 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_239eb2b77f16b93a10fdc0c6ed5557cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3a9862513491ef51bfbe923afceaaa1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0284de848d4cdc5fa4e212f84b37ab35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e33a0812c617ccf075cc085316dc2bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_728a3b1954d3771347bd8f5e211e1931 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13eb286d9b8ba83844d97d2fe298457f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_113bb793940fa08ad197b25cd283fd7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a3493b4366e67d5835a40779ce8b03e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69111aad2958cc671e7a0ce2bde17ddc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9f41fdd437a209df70627756bf87c1b
date	201107
identifier	https://pubmed.ncbi.nlm.nih.gov/21742095 https://doi.org/10.1016/j.ahj.2011.04.015
isPartOf	https://portal.issn.org/resource/ISSN/0002-8703 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/398
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
discusses	http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0155432
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017202Q000517 http://id.nlm.nih.gov/mesh/D010975Q000009 http://id.nlm.nih.gov/mesh/D013988Q000031 http://id.nlm.nih.gov/mesh/D006470Q000401 http://id.nlm.nih.gov/mesh/D050197Q000150 http://id.nlm.nih.gov/mesh/D013927Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015996Q000639 http://id.nlm.nih.gov/mesh/D002423Q000639 http://id.nlm.nih.gov/mesh/D014943 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013927Q000150 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013988Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013988Q000009 http://id.nlm.nih.gov/mesh/D000077144 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D017202Q000209 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D013927Q000401 http://id.nlm.nih.gov/mesh/D006470Q000139 http://id.nlm.nih.gov/mesh/D050197Q000188 http://id.nlm.nih.gov/mesh/D017202Q000453
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075

Total number of triples: 72.